Delivery Order SPE2DX15D9904-SPE2DX24FAFA4

Award Date 8/20/24
Potential Completion Date 8/21/24
Potential Value $3.8K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,226.96 firm fixed-price delivery order is for the supply of ALBENDAZOLE TABLETS, a pharmaceutical product, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA), a Department of Defense (DoD) agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,120.72 firm fixed-price delivery order is for the provision of ALBENDAZOLE TABLETS, a pharmaceutical product, with a completion date of September 20, 2024. DMS Pharmaceutical Group holds a large indefinite delivery contract (IDC) with the DLA under the...
The U.S. government awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,238.53 contract, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program, is for the delivery of ALBENDAZOLE TABLETS. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which runs through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,421.00 firm fixed-price delivery order is for the procurement of ALBENDAZOLE TABLETS, with a completion date of August 19, 2024. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,301.54 firm fixed-price delivery order is for the supply of Albendazole tablets, with a period of performance through August 21, 2024. The contract is not associated with a set-aside program. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,432.34 firm fixed-price delivery order is for the supply of Albendazole tablets and is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program. This IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical products to fulfill...
This federal contract award, valued at $8,326.08, was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order (SPE2DX24FASRB) for the supply of Albendazole tablets. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, valued at $8,326.08, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,565,095,616 Albendazole tablets to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,089.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has no set-aside designation, is for the provision of the drug Albendazole 200 mg tablets. This order is issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to issue...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,455.04 firm fixed-price delivery order is for the supply of Albendazole tablets, a medication primarily used to treat parasitic infections. The award is made under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA's Medical Supply Chain division, which...
  • SPE2DX15D9904
    Indefinite Delivery Contract
  • SPE2DX15D9904-SPE2DX24FAFA4
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,776.48 firm fixed-price delivery order is for the supply of ALBENDAZOLE TABLETS and does not have a set-aside designation.

DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. Through this vehicle, DMS Pharmaceutical Group provides both routine and critical medications to support the diverse medical requirements of the Department of Defense healthcare system.

Generated 11/19/24, 9:03 AM